Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
治療
Document Type and Number:
Japanese Patent JP6925274
Kind Code:
B2
Abstract:
The invention provides an antibody or fragment thereof that specifically binds to human Lrg1.

More Like This:
WO/2003/006996NATURAL LIGAND OF GPCR CHEMR23 AND USES THEREOF
JP2002533422INDUSTRIAL APPLICABILITY A method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia.
JP2004201684TREATING BREAST CANCER
Inventors:
Trypasi, Vineta
Sheridan, rose
John Greenwood
Moss, steven
Application Number:
JP2017545403A
Publication Date:
August 25, 2021
Filing Date:
February 22, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UCL Business Limited
International Classes:
C07K16/18; A61K38/17; A61K39/395; A61K45/00; A61P9/00; A61P27/02; A61P35/00; A61P43/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13
Domestic Patent References:
JP2013503621A
Foreign References:
WO2013132267A1
Attorney, Agent or Firm:
Hiraki International Patent Office



 
Previous Patent: 補助デバイスを有する注射デバイス

Next Patent: 皮膚用の医薬組成物